Pharma/ Biotechnology Investments Specialist, Vasuda Capital Management

Dr. Bhavneesh Sharma, MD, MBA

Pharma/ Biotechnology Investments Specialist

Vasuda Capital Management

Equity Bottom-Up

<p><a href="https://www.smartkarma.com/entities/17582" target="_blank" data-smartkarma-citation="entities:17582:1">Immune Design Corp (IMDZ US)</a> is an emerging immuno-oncology company (based in Seattle, Washington) that is using its proprietary technology in various cancers like sarcomas and lymphomas. The company's common stock price has recently rebounded off the lows after strong institutional and insider buying, and encouraging clinical data from some product candidates.</p><p>We see compelling value in Immune Design common stock at this level. Our first price target for the common stock is $20 (&gt;150% potential upside). There are several near-term catalysts that could provide upward boost to the stock price.</p>

Immune Design Corp (IMDZ US) is an emerging immuno-oncology company (based in Seattle, Washington) that is using its proprietary technology in various cancers like sarcomas and lymphomas. The company's common stock price has recently rebounded off the lows after strong institutional and insider buying, and encouraging clinical data from some product candidates.We see compelling value in Immune Design common stock at this level. Our first price target for the common stock is $20 (&gt;150% potential upside). There are several near-term catalysts that could provide upward boost to the stock price.

New Long Position: 'Red Bull' like Immune Boost Against Cancer